In a cross-sectional evaluation printed in JAMA Community Open, Austin Wesevich, MD, MPH, MS, and colleagues examined whether or not adverse language within the EHR clusters round sickle cell illness (SCD) itself or across the overlapping stigmas that usually have an effect on these sufferers: Black race, ache, and opioid publicity.
The dataset for the examine, drawn from the College of Chicago hospital, was sizable: 39,871 clinician notes associated to 18,326 sufferers, spanning inpatient, outpatient, and emergency division encounters. Notes from January 1, 2019, by means of October 1, 2020, had been analyzed with pure language processing and machine studying to establish seven adverse descriptors utilized in context: aggressive, agitated, offended, nonadherent, noncompliant, noncooperative, and refuse. Sufferers with SCD had been in contrast with 4 non-SCD teams: Black sufferers, sufferers with power ache, sufferers with opioid use dysfunction (OUD), and a counterfactual group of non-Black sufferers with out power ache or OUD.
One apparent query for clinicians is whether or not biased documentation associated to SCD is pushed extra by race, by ache, or by the stigma that follows opioid remedy. One other is whether or not language within the chart turns into a mechanism by which bias is transmitted from one encounter to the following.
Unfavorable descriptors appeared in 220 of 1,443 notes for sufferers with SCD, or 15%. The commonest adverse descriptors had been refuse, noncompliant, and nonadherent. By comparability, adverse descriptors appeared in 14% of notes for sufferers with OUD, 7% for Black sufferers with out SCD, 7% for sufferers with power ache with out SCD, and three% for the counterfactual group. Sufferers carrying all three stigmatizing disease-related and racial identities had the best frequency, with adverse descriptors in 19% of notes.
As Dr. Wesevich identified in forwarded written feedback, “Our examine confirmed that 15% of notes for sufferers with sickle cell illness included a adverse descriptor, with the most typical adverse descriptors being refuse, noncompliant, and nonadherent.” That discovering is tough to disregard, however the adjusted analyses are what make the examine clinically vital.
After adjustment for intercourse, age group, marital standing, encounter setting, insurance coverage, and Charlson Comorbidity Index, sufferers with SCD had considerably greater odds of getting a adverse descriptor than Black sufferers with out SCD, sufferers with power ache with out SCD, and sufferers within the counterfactual group, with adjusted odds ratios (aORs) of two.46, 1.96, and 14.26, respectively. Odds had been much like these seen in sufferers with OUD with out SCD, at an aOR of 0.76. In sensitivity analyses restricted to Black sufferers, these with SCD nonetheless had greater odds of getting a adverse descriptor than Black sufferers with power ache, at an aOR of 1.97 however decrease odds than Black sufferers with OUD, at an aOR of 0.49.
That sample helps Dr. Wesevich’s interpretation: “Sufferers with sickle cell illness had greater odds of a adverse descriptor of their notes than Black sufferers or sufferers with power ache, however they’d related odds as sufferers with opioid use dysfunction.” He added, “Our findings counsel that sufferers with sickle cell illness probably expertise each race-based and disease-related biases. The stigma related to opioids probably impacts sickle cell care.”
The scientific implication is just not summary. Vaso-occlusive ache is without doubt one of the predominant causes sufferers with SCD current for acute care, and people encounters typically rely upon speedy selections about analgesia, belief, and adherence. This examine means that the EHR itself can encode stigma, particularly round opioid-treated ache, and carry it ahead into future care.
